erika hamilton, md | when to use cdk 4/6 inhibitors
Published 7 years ago • 173 plays • Length 1:38
Download video MP4
Download video MP3
Similar videos
-
2:21
erika hamilton, md, regarding the use of cdk 4/6 inhibitors in clinical practice
-
1:12
erika hamilton, md, on how cdk4/6 inhibitors transformed the management of metastatic breast cancer
-
1:37
dr. han on the differences between cdk 4/6 inhibitors in er breast cancer
-
1:13
erika hamilton, md, considers the significance of the monarche study & the use of abemaciclib
-
8:42
hr mbc: treatment after progression on cdk4/6 inhibition
-
26:14
metastatic breast cancer | 2022 oneoncology conference
-
17:54
expert perspectives: cdk 4/6 inhibitors for er breast cancer: current data and clinical use
-
1:13
erika hamilton, md, shares thoughts on tolerability in high risk early breast cancer patients
-
54:38
what is the relationship between estrogen and breast cancer? | dr. avrum bluming
-
1:01:33
watch: menopause, breast cancer, and the journey forward | dr. avrum bluming & dr. corinne menn
-
59:35
report back from asco 2024: latest updates on metastatic breast cancer (mbc)
-
13:05
expert perspectives: cdk 4/6 inhibitor therapy for er metastatic breast cancer
-
1:06
priya rastogi, md, considers the interchangeability of cdk 4/6 inhibitors
-
10:02
expert perspectives: cdk 4/6 inhibitors for er breast cancer: emerging data and future implications
-
8:04
key takeaways from esmo: cdk4/6 inhibitors for metastatic hr /her2- breast cancer
-
4:15
hr breast cancer: factors in selecting a cdk4/6 inhibitor
-
0:57
dr. erika p. hamilton on ont-380 for her2 breast cancer
-
0:47
dr. hamilton on the addition of biosimilars to breast oncology
-
1:27
erika hamilton, md, provides perspective on the latest immunotherapy treatment trends in tnbc
-
4:15
case 2: choosing a cdk4/6 inhibitor in er breast cancer
-
44:03
ask the expert: understanding the latest advances in breast cancer
-
1:53
dr. hamilton on adjuvant therapy for her2 breast cancer
Clip.africa.com - Privacy-policy